Advertisement
Imaging
Subscribe to Imaging
View Sample

FREE Email Newsletter

Conatus Pharmaceuticals Acquires Pfizer's Idun Subsidiary

July 30, 2010 12:39 pm | by Bio-Medicine.Org | News | Comments

SAN DIEGO , July 30 /- Conatus Pharmaceuticals Inc. announced today that Conatus acquired the Idun Pharmaceuticals subsidiary of Pfizer Inc.  Financial terms were not disclosed.  Conatus Pharmaceuticals is a privately-held drug development company focused on liver disease and...

CareFusion Will Host an Earnings Conference Call on Aug. 10 to Discuss the Results for the Fourth Quarter and Fiscal 2010

July 30, 2010 12:39 pm | by Bio-Medicine.Org | News | Comments

SAN DIEGO , July 30 /- CareFusion Corporation (NYSE: CFN ) today announced plans to release fourth quarter and fiscal 2010 results on Tuesday, Aug. 10 following the close of trading on the New York Stock Exchange. The company will host a webcast and conference call on Aug. 10 at 2 p.m....

Water Street Healthcare Partners Announces New Investment in Medical Specialties Distributors, LLC

July 30, 2010 8:35 am | by Bio-Medicine.Org | News | Comments

CHICAGO , July 30 /- Water Street Healthcare Partners , a leading private equity firm focused exclusively on health care, announced today that it has acquired Medical Specialties Distributors, LLC (MSD).  Headquartered in Stoughton, Massachusetts , MSD is the nation's leading...

Advertisement

FDA CONSUMER HEALTH INFORMATION - Keep Kids, Pets Away From Skin Sprayed With Evamist

July 29, 2010 12:37 pm | by Bio-Medicine.Org | News | Comments

SILVER SPRING, Md. , July 29 /PRNewswire-USNewswire/ -- The Food and Drug Administration (FDA) says children and pets should not come in contact with Evamist, a topical drug for women used in the treatment of hot flashes caused by menopause. (Logo:...

Launch of BioOptimalâ„¢ MF-SL Microfilters for Bioprocessing

July 29, 2010 12:37 pm | by Bio-Medicine.Org | News | Comments

TOKYO , July 29 /- Asahi Kasei Medical Co., Ltd. is pleased to announce the commercial launch on August 1 of BioOptimal™ MF-SL, its new range of microfilters for bioprocessing applications. Designed specifically for use in cell culture clarification applications, BioOptimal™...

Giant Eagle® Expands Free Prescription Program to Include Free Diabetes Medicines in Northeast Ohio

July 29, 2010 9:34 am | by Bio-Medicine.Org | News | Comments

CLEVELAND , July 29 /- With diabetes affecting the lives of hundreds of thousands of people throughout Ohio and Pennsylvania , Giant Eagle®, Inc. has announced that it will begin offering five commonly prescribed medications for the treatment of type 2 diabetes at no cost to medical...

Giant Eagle® Expands Free Prescription Program To Include Free Diabetes Medicines in Western Pennsylvania

July 29, 2010 9:34 am | by Bio-Medicine.Org | News | Comments

PITTSBURGH , July 29 /- With diabetes affecting the lives of hundreds of thousands of people throughout Pennsylvania and Ohio , Giant Eagle®, Inc. has announced that it will begin offering five commonly prescribed medications for the treatment of type 2 diabetes at no cost to medical...

NCPA Statement on CVS Caremark-Aetna Agreement

July 29, 2010 9:34 am | by Bio-Medicine.Org | News | Comments

ALEXANDRIA, Va. , July 29 /PRNewswire-USNewswire/ -- In response to the agreement announced that CVS Caremark would provide pharmacy benefits to all 9.7 million lives covered by insurance giant Aetna, the National Community Pharmacists Association (NCPA) issued the following statement...

Advertisement

Walter H.C. Drakeford Named Co-President and Co-Chairman of the Board of Directors for MIT Holding, Inc.

July 29, 2010 9:34 am | by Bio-Medicine.Org | News | Comments

SAVANNAH, Ga. , July 29 /- MIT Holding, Inc. announces that Walter H.C. Drakeford has been named co-president and co-chairman of the board of directors. MIT Holding, Inc. founder William "Rocky" Parker will also serve as co-president and co-chairman of the board of directors. Drakeford's...

Analysis Finds U.S. Medical-Surgical Manufacturers Using GHX Market Intelligence Grew Revenue Faster Than Non-Users in 2009

July 29, 2010 9:34 am | by Bio-Medicine.Org | News | Comments

LOUISVILLE, Colo. , July 29 /- An analysis of medical-surgical sales through distribution conducted by GHX has found that among the top 100 U.S. medical-surgical manufacturers by dollar spend, those that use GHX Market Intelligence data grew medical-surgical revenue through distribution...

Vermillion to Host Conference Call and Web Cast to Present Company Update and Review Financial Results for the Second Quarter 2010

July 29, 2010 9:34 am | by Bio-Medicine.Org | News | Comments

AUSTIN, Texas ,  July 29 /- Vermillion, Inc. (Nasdaq: VRML ), a molecular diagnostics company, will host a web cast and conference call to give a company update following issuance of Q2 financial results on Monday, August 16, 2010 . Conference Call Information To access the live...

Intra-Cellular Therapies Announces the Successful Completion of a Phase Ib/II Study of ITI-007 in Patients with Schizophrenia

July 29, 2010 6:35 am | by Bio-Medicine.Org | News | Comments

NEW YORK , July 29 /- Intra-Cellular Therapies, Inc. today announced the results from a Phase Ib/II clinical trial in patients with schizophrenia with ITI-007, the Company's unique, investigational new drug for the treatment of schizophrenia.  The trial met its primary endpoint...

ANA598 Demonstrates SVR12 in 100% of First Group of HCV Patients Randomized to Stop All Treatment at Week 24

July 29, 2010 4:37 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO , July 29 /- Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS ) today announced that six of six patients (100%) in the ANA598 200 mg twice daily (bid) arm who were randomized to stop all treatment at Week 24 in an ongoing Phase II trial maintained undetectable levels of virus 12 weeks...

Advertisement

Free For All® Inc., MMM and PMC Assist Members with Pharmacy Discount

July 29, 2010 4:37 am | by Bio-Medicine.Org | News | Comments

MARLTON, N.J. , July 29 /- Free For All® Inc., MMM Healthcare, Inc. (MMM) and PMC Medicare Choice, Inc. today announced a plan to offer MMM/PMC members access to medications, lab testing and medical imaging at substantial rate reductions with the use of RxCut®Plus cards. The...

FDA CONSUMER HEALTH INFORMATION - Combating Misuse and Abuse of Prescription Drugs: Q & A with Michael Klein, Ph.D.

July 28, 2010 12:34 pm | by Bio-Medicine.Org | News | Comments

SILVER SPRING, Md. , July 28 /PRNewswire-USNewswire/ -- Dr. Michael Klein , director of the Food and Drug Administration (FDA) Controlled Substance Staff, discusses how FDA works with other entities to confront and to prevent misuse and abuse of prescription drugs.   (Logo:...

New FDLI Monograph Provides Expert Guidance on Selling Pharmaceuticals, Biologics to Federal Government

July 28, 2010 12:34 pm | by Bio-Medicine.Org | News | Comments

WASHINGTON , July 28 /PRNewswire-USNewswire/ -- In FDLI's latest monograph, Selling Pharmaceuticals and Biologics to the Federal Government: Federal Supply Schedule and Federal Pricing Requirements , Joy Sturm , Allison Pugsley and Stephen A. Smyers of Hogan Lovells US LLP detail how...

U.S. Court of Appeals Rules on Validity of Lilly's Gemzar Method-of-Use Patent

July 28, 2010 12:34 pm | by Bio-Medicine.Org | News | Comments

INDIANAPOLIS , July 28 /- Eli Lilly and Company (NYSE: LLY ) today announced that the U.S. Court of Appeals for the Federal Circuit has upheld a prior ruling by the U.S. District Court for the Eastern District of Michigan that Gemzar's method-of-use patent is invalid. "We strongly...

Southwest Hospitals MRI Center's Commitment to State-of-the-Art Technology at the Heart of Nearly 20-Year Relationship with MedInformatix RIS

July 28, 2010 9:35 am | by Bio-Medicine.Org | News | Comments

LOS ANGELES , July 28 /- Since its formation in 1987, Oak Lawn, Ill. -based Southwest Hospitals MRI Center has leveraged cutting edge imaging and other technology to provide the community just southwest of Chicago with among the area's highest quality MRI studies. Each of its technicians...

Bionovo, Inc. to Announce Second Quarter Fiscal Year 2010 Financial Results on Wednesday, August 4, 2010

July 28, 2010 6:33 am | by Bio-Medicine.Org | News | Comments

EMERYVILLE, Calif. , July 28 /- Bionovo, Inc. (Nasdaq: BNVI ) announced today that it will release financial results for the second quarter of fiscal year 2010 ended June 30, 2010 on Wednesday, August 4, 2010 . The Company will conduct a conference call and webcast to review the financial...

Warner Chilcott Announces Earnings Release Date and Conference Call for Second Quarter 2010 Financial Results

July 28, 2010 6:33 am | by Bio-Medicine.Org | News | Comments

ARDEE, Ireland , July 28 /- Warner Chilcott plc (Nasdaq: WCRX) today announced that it will issue its second quarter 2010 financial results prior to the market opening on Friday, August 6, 2010 . In addition to issuing a press release, the Company will host a conference call for all...

Topaz Pharmaceuticals Announces Positive Data from Topical Ivermectin Trials Presented at Society of Pediatric Dermatology

July 28, 2010 5:39 am | by Bio-Medicine.Org | News | Comments

HORSHAM, Pa. , July 28 /- Topaz Pharmaceuticals Inc., a privately held biotechnology company, announced positive results of studies of topical ivermectin cream, which it is developing as a potential  treatment of Pediculus humanus capitis (head lice).   In a Phase 2 dose-ranging...

Accuray Incorporated to Report Financial Results for Fourth Quarter and Fiscal Year 2010

July 28, 2010 5:39 am | by Bio-Medicine.Org | News | Comments

SUNNYVALE, Calif. , July 28 /- Accuray Incorporated (Nasdaq: ARAY ), a global leader in the field of radiosurgery, today announced that it will report results for its fourth quarter and fiscal year 2010, ended June 30, 2010 on Tuesday, August 31, 2010 after the market closes. A conference...

EMD Serono, Inc.: FDA Grants Priority Review to Cladribine Tablets for the Treatment of Relapsing Forms of MS

July 28, 2010 2:35 am | by Bio-Medicine.Org | News | Comments

ROCKLAND, Mass. , July 28 /- EMD Serono, Inc., an affiliate of Merck KGaA, Darmstadt, Germany , announced today that the U.S. Food and Drug Administration (FDA) has accepted for filing the New Drug Application (NDA) for Cladribine Tablets as a therapy for relapsing forms of multiple...

BioElectronics and YesDTC Holdings Receive Japanese Regulatory Review Date

July 27, 2010 4:35 am | by Bio-Medicine.Org | News | Comments

FREDERICK, Md. , July 27 /- BioElectronics Corp. (Pink Sheets: BIEL), manufacturers of innovative pain relieving medical devices, today announced its distribution partner for Japan , YesDTC Holdings, Inc. (OTC Bulletin Board: YESD) has received notification from its legal staff of the...

YesDTC Holdings and BioElectronics Receive Japanese Regulatory Review Date

July 27, 2010 4:35 am | by Bio-Medicine.Org | News | Comments

SAN FRANCISCO , July 27 /- YesDTC Holdings, Inc. (OTC Bulletin Board: YESD), a direct-to-consumer marketer and global distributor of consumer goods and products and BioElectronics Corp. (Pink Sheets: BIEL), manufacturers of innovative pain relieving medical devices, today announced the...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading